Inhibition of five xenografted human cancers and two murine cancers by the tripeptide tyroservatide-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of five xenografted human cancers and two murine cancers by the tripeptide tyroservatide

Published:2007-04 Issue:4 Volume:18 Page:467-470
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Fu Zheng,Lu Rong,Jia Jing,Zhao Lan,Ma Rui,Lv Jun-qiang,Li Xiao-lei,Chen Li-juan,Zhang Hua-li,Wang Li,Yao Zhi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference10 articles.

1. Preliminary investigation of the inhibitory effects of the tyroservaltide (YSV) tripeptide on human hepatocarcinoma BEL-7402;Jia;Cancer Biol Ther,2005

2. Expression of PTEN, p27, p21 and AKT mRNA and protein in human BEL-7402 hepatocarcinoma cells in transplanted tumors of nude mice treated with the tripeptide tyroservatide (YSV);Zhu;Int J Cancer,2006

3. Gene-chip analysis of the effect of tripeptide tyroservatide (YSV) on gene-expression in human hepatocarcinoma BEL-7402 tumors transplanted to nude mice;Jia;Mol Carcinog,2006

4. Cancer statistics, 2004;Jemal;CA Cancer J Clin,2004

5. Nude mice as models for human leukemia studies;Potter;Am J Pathol,1984

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic apoptotic effects of apigenin TPGS liposomes and tyroservatide: implications for effective treatment of lung cancer;International Journal of Nanomedicine;2017-07

2. Tyroservatide-TPGS-paclitaxel liposomes: Tyroservatide as a targeting ligand for improving breast cancer treatment;Nanomedicine: Nanotechnology, Biology and Medicine;2017-04

3. Therapeutic effects of tyroservatide on metastasis of lung cancer and its mechanism affecting integrin–focal adhesion kinase signal transduction;Drug Design, Development and Therapy;2016-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3